ADXN
Price
$8.37
Change
+$0.54 (+6.90%)
Updated
Jul 23, 12:14 PM (EDT)
Capitalization
9.41M
PHAT
Price
$8.56
Change
+$0.66 (+8.35%)
Updated
Jul 23, 04:59 PM (EDT)
Capitalization
551.53M
15 days until earnings call
Interact to see
Advertisement

ADXN vs PHAT

Header iconADXN vs PHAT Comparison
Open Charts ADXN vs PHATBanner chart's image
Addex Therapeutics
Price$8.37
Change+$0.54 (+6.90%)
Volume$201
Capitalization9.41M
Phathom Pharmaceuticals
Price$8.56
Change+$0.66 (+8.35%)
Volume$18.43K
Capitalization551.53M
ADXN vs PHAT Comparison Chart in %
Loading...
ADXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADXN vs. PHAT commentary
Jul 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADXN is a Hold and PHAT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 24, 2025
Stock price -- (ADXN: $8.12 vs. PHAT: $7.83)
Brand notoriety: ADXN and PHAT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADXN: 21% vs. PHAT: 25%
Market capitalization -- ADXN: $9.41M vs. PHAT: $551.53M
ADXN [@Biotechnology] is valued at $9.41M. PHAT’s [@Biotechnology] market capitalization is $551.53M. The market cap for tickers in the [@Biotechnology] industry ranges from $284.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADXN’s FA Score shows that 2 FA rating(s) are green whilePHAT’s FA Score has 0 green FA rating(s).

  • ADXN’s FA Score: 2 green, 3 red.
  • PHAT’s FA Score: 0 green, 5 red.
According to our system of comparison, ADXN is a better buy in the long-term than PHAT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADXN’s TA Score shows that 6 TA indicator(s) are bullish while PHAT’s TA Score has 3 bullish TA indicator(s).

  • ADXN’s TA Score: 6 bullish, 5 bearish.
  • PHAT’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ADXN is a better buy in the short-term than PHAT.

Price Growth

ADXN (@Biotechnology) experienced а -9.79% price change this week, while PHAT (@Biotechnology) price change was -13.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.08%. For the same industry, the average monthly price growth was +21.29%, and the average quarterly price growth was +31.06%.

Reported Earning Dates

ADXN is expected to report earnings on May 15, 2025.

PHAT is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+7.08% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHAT($552M) has a higher market cap than ADXN($9.41M). ADXN YTD gains are higher at: 15.986 vs. PHAT (-3.571). ADXN has higher annual earnings (EBITDA): -12.19M vs. PHAT (-272.12M). PHAT has more cash in the bank: 212M vs. ADXN (3.35M). ADXN has less debt than PHAT: ADXN (43.8K) vs PHAT (204M). PHAT has higher revenues than ADXN: PHAT (81.9M) vs ADXN (556K).
ADXNPHATADXN / PHAT
Capitalization9.41M552M2%
EBITDA-12.19M-272.12M4%
Gain YTD15.986-3.571-448%
P/E RatioN/AN/A-
Revenue556K81.9M1%
Total Cash3.35M212M2%
Total Debt43.8K204M0%
TECHNICAL ANALYSIS
Technical Analysis
ADXNPHAT
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 17 days ago
77%
Bullish Trend 14 days ago
84%
Declines
ODDS (%)
Bearish Trend 6 days ago
87%
Bearish Trend 6 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
87%
Aroon
ODDS (%)
Bullish Trend 6 days ago
81%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
ADXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
UGOFX12.030.02
+0.17%
Victory Global Managed Volatility Instl
GGGPX42.64N/A
N/A
Goldman Sachs Large Cap Equity P
NSFOX11.58N/A
N/A
Natixis Target Retirement 2065 N
HRITX13.42-0.03
-0.22%
Hood River International Opportunity Ret
KAUFX6.09-0.02
-0.33%
Federated Hermes Kaufmann R

ADXN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADXN has been loosely correlated with ANVS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ADXN jumps, then ANVS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADXN
1D Price
Change %
ADXN100%
+7.68%
ANVS - ADXN
43%
Loosely correlated
-4.53%
CVM - ADXN
39%
Loosely correlated
+9.85%
PHAT - ADXN
28%
Poorly correlated
-1.51%
MOLN - ADXN
27%
Poorly correlated
+7.09%
SGMO - ADXN
26%
Poorly correlated
-3.06%
More

PHAT and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHAT has been loosely correlated with TNFA. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if PHAT jumps, then TNFA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHAT
1D Price
Change %
PHAT100%
-1.51%
TNFA - PHAT
39%
Loosely correlated
+47.89%
ATRA - PHAT
36%
Loosely correlated
+15.00%
RGNX - PHAT
35%
Loosely correlated
+4.04%
URGN - PHAT
35%
Loosely correlated
+1.24%
CCCC - PHAT
34%
Loosely correlated
-2.37%
More